Securities code: 688277 securities abbreviation: Tinavi Medical Technologies Co.Ltd(688277) Announcement No.: 2021-076 Tinavi Medical Technologies Co.Ltd(688277)
Notice on receiving the review opinions on issuing shares to specific objects
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as “the company”) received the notice on the examination opinions on Tinavi Medical Technologies Co.Ltd(688277) issuing shares to specific objects from the listing examination center of Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”) on December 27, 2021. The specific opinions are as follows: I. examination opinions
Tinavi Medical Technologies Co.Ltd(688277) the application for issuing shares to specific objects meets the issuance conditions, listing conditions and information disclosure requirements.
2、 Implementation issues
The issuer is requested to comprehensively sort out the contents of the chapter “risk factors related to this issuance”, fully reveal the “R & D risk of the new generation orthopedic surgery Siasun Robot&Automation Co.Ltd(300024) ” project “and” the risk that the company will not be profitable in the short term “in combination with the company’s product sales and customer development, and highlight the pertinence of information disclosure.
The company’s issuance of shares to specific objects (hereinafter referred to as “this issuance”) still needs the company to implement and reply to the questions raised by the audit opinions. After receiving the reply of the company’s implementation opinions, Shanghai Stock Exchange will submit it to China Securities Regulatory Commission (hereinafter referred to as “CSRC”) ）Registration. There is still uncertainty whether the issuance can finally be registered with the CSRC. The company will timely perform the obligation of information disclosure according to the review progress of the matter and in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to the investment risks.
It is hereby announced.
Tinavi Medical Technologies Co.Ltd(688277) board of directors December 28, 2021
